Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men-Reference-Cited by-同舟云学术

Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men

Published:2015-10-02 Issue:1 Volume:84 Page:107-114
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Yassin Aksam¹²³,Almehmadi Yousef¹²³,Saad Farid²⁴,Doros Gheorghe⁵,Gooren Louis⁶

Affiliation:

1. Institute of Urology and Andrology; Segeberger Kliniken; Norderstedt Germany

2. Gulf Medical University; Ajman UAE

3. Dresden International University; Dresden Germany

4. Global Medical Affairs Men's Healthcare; Bayer Pharma AG; Berlin Germany

5. Department of Epidemiology and Statistics; Boston University School of Public Health; Boston MA USA

6. Department of Internal Medicine; Endocrine Section; VU medical Center; Amsterdam The Netherlands

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference25 articles.

1. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment;Huhtaniemi;Asian Journal of Andrology,2014

2. Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life;Biswas;Clinical Endocrinology (Oxford),2012

3. Three definitions of me syndrome applied to a sample of young obese men and their relation with plasma testosterone;Goncharov;Aging Male,2008

4. Testosterone and mortality;Muraleedharan;Clinical Endocrinology (Oxford),2014

5. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men;Lunenfeld;Aging Male,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRACK_9: Testosterone replacement assessment: Classical vs. functional hypogonadism‐knowledge from a 9‐year study;Andrology;2024-03-15

2. EMAS position statement: Testosterone replacement therapy in older men;Maturitas;2023-12

3. New perspectives in functional hypogonadotropic hypogonadism: beyond late onset hypogonadism;Frontiers in Endocrinology;2023-06-29

4. Testosterone treatment and change of categories of the International prostate symptom score (IPSS) in hypogonadal patients: 12 years prospective controlled registry study;The Aging Male;2023-06-07

5. Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size;International Urology and Nephrology;2023-05-06